166 related articles for article (PubMed ID: 16337133)
21. Sarm1 knockout modifies biomarkers of neurodegeneration and spinal cord circuitry but not disease progression in the mSOD1
Collins JM; Atkinson RAK; Matthews LM; Murray IC; Perry SE; King AE
Neurobiol Dis; 2022 Oct; 172():105821. PubMed ID: 35863521
[TBL] [Abstract][Full Text] [Related]
22. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Kaiser M; Maletzki I; Hülsmann S; Holtmann B; Schulz-Schaeffer W; Kirchhoff F; Bähr M; Neusch C
J Neurochem; 2006 Nov; 99(3):900-12. PubMed ID: 16925593
[TBL] [Abstract][Full Text] [Related]
23. Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model.
Gomes C; Cunha C; Nascimento F; Ribeiro JA; Vaz AR; Brites D
Mol Neurobiol; 2019 Mar; 56(3):2137-2158. PubMed ID: 29995256
[TBL] [Abstract][Full Text] [Related]
24. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.
Martin LJ; Liu Z; Chen K; Price AC; Pan Y; Swaby JA; Golden WC
J Comp Neurol; 2007 Jan; 500(1):20-46. PubMed ID: 17099894
[TBL] [Abstract][Full Text] [Related]
25. Differential screening of mutated SOD1 transgenic mice reveals early up-regulation of a fast axonal transport component in spinal cord motor neurons.
Dupuis L; de Tapia M; René F; Lutz-Bucher B; Gordon JW; Mercken L; Pradier L; Loeffler JP
Neurobiol Dis; 2000 Aug; 7(4):274-85. PubMed ID: 10964600
[TBL] [Abstract][Full Text] [Related]
26. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.
Liao B; Zhao W; Beers DR; Henkel JS; Appel SH
Exp Neurol; 2012 Sep; 237(1):147-52. PubMed ID: 22735487
[TBL] [Abstract][Full Text] [Related]
27. Increased cytotoxic potential of microglia from ALS-transgenic mice.
Weydt P; Yuen EC; Ransom BR; Möller T
Glia; 2004 Nov; 48(2):179-82. PubMed ID: 15378658
[TBL] [Abstract][Full Text] [Related]
28. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
29. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.
Butovsky O; Siddiqui S; Gabriely G; Lanser AJ; Dake B; Murugaiyan G; Doykan CE; Wu PM; Gali RR; Iyer LK; Lawson R; Berry J; Krichevsky AM; Cudkowicz ME; Weiner HL
J Clin Invest; 2012 Sep; 122(9):3063-87. PubMed ID: 22863620
[TBL] [Abstract][Full Text] [Related]
30. Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype.
Roberts K; Zeineddine R; Corcoran L; Li W; Campbell IL; Yerbury JJ
Glia; 2013 Mar; 61(3):409-19. PubMed ID: 23281114
[TBL] [Abstract][Full Text] [Related]
31. The adult neural stem and progenitor cell niche is altered in amyotrophic lateral sclerosis mouse brain.
Liu Z; Martin LJ
J Comp Neurol; 2006 Jul; 497(3):468-88. PubMed ID: 16736475
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
[TBL] [Abstract][Full Text] [Related]
33. The cellular mRNA expression of GABA and glutamate receptors in spinal motor neurons of SOD1 mice.
Petri S; Schmalbach S; Grosskreutz J; Krampfl K; Grothe C; Dengler R; Van Den Bosch L; Robberecht W; Bufler J
J Neurol Sci; 2005 Nov; 238(1-2):25-30. PubMed ID: 16087196
[TBL] [Abstract][Full Text] [Related]
34. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
Chi L; Ke Y; Luo C; Gozal D; Liu R
Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
[TBL] [Abstract][Full Text] [Related]
35. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
36. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
Feng X; Peng Y; Liu M; Cui L
Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
[TBL] [Abstract][Full Text] [Related]
37. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis.
Baron P; Bussini S; Cardin V; Corbo M; Conti G; Galimberti D; Scarpini E; Bresolin N; Wharton SB; Shaw PJ; Silani V
Muscle Nerve; 2005 Oct; 32(4):541-4. PubMed ID: 15962273
[TBL] [Abstract][Full Text] [Related]
38. Assessing the role of immuno-proteasomes in a mouse model of familial ALS.
Puttaparthi K; Van Kaer L; Elliott JL
Exp Neurol; 2007 Jul; 206(1):53-8. PubMed ID: 17482163
[TBL] [Abstract][Full Text] [Related]
39. Microglial keratan sulfate epitope elicits in central nervous tissues of transgenic model mice and patients with amyotrophic lateral sclerosis.
Foyez T; Takeda-Uchimura Y; Ishigaki S; Narentuya ; Zhang Z; Sobue G; Kadomatsu K; Uchimura K
Am J Pathol; 2015 Nov; 185(11):3053-65. PubMed ID: 26362733
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of miR-124 in Motor Neurons Plays a Key Role in ALS Pathological Processes.
Vaz AR; Vizinha D; Morais H; Colaço AR; Loch-Neckel G; Barbosa M; Brites D
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
